Simplex Trading’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.7K Sell
43
-4,930
-99% -$510K ﹤0.01% 8216
2026
Q1
$517K Buy
4,973
+2,510
+102% +$267K ﹤0.01% 3216
2025
Q4
$254K Buy
+2,463
New +$240K ﹤0.01% 3984
2024
Q4
Sell
-84
Closed -$7K 9379
2024
Q3
$7K Buy
+84
New +$7.98K ﹤0.01% 7447
2023
Q2
Sell
-70
Closed -$5K 9725
2023
Q1
$5K Buy
+70
New +$5.4K ﹤0.01% 8065
2022
Q3
Sell
-8,051
Closed -$618K 10670
2022
Q2
$618K Buy
8,051
+7,961
+8,846% +$622K ﹤0.01% 3196
2022
Q1
$7K Buy
+90
New +$6.89K ﹤0.01% 9194
2019
Q1
Sell
-26
Closed -$1K 7701
2018
Q4
$1K Buy
+26
New +$1.57K ﹤0.01% 6772
2017
Q2
Sell
-268
Closed -$14K 6635
2017
Q1
$14K Buy
+268
New +$14.5K ﹤0.01% 3651
2016
Q4
Sell
-272
Closed -$15K 6380
2016
Q3
$15K Sell
272
-2,740
-91% -$164K ﹤0.01% 3264
2016
Q2
$176K Buy
3,012
+2,299
+322% +$134K 0.01% 1080
2016
Q1
$40K Buy
713
+225
+46% +$13.3K ﹤0.01% 2151
2015
Q4
$31K Sell
488
-632
-56% -$40.8K ﹤0.01% 2316
2015
Q3
$70K Buy
+1,120
New +$78.7K 0.01% 1722

Other funds holding PPH

Simplex Trading's PPH Position: Q2 2026 in Review

Simplex Trading reduced its VanEck Pharmaceutical ETF (PPH) stake by 99% in Q2 2026, selling an estimated $510K and leaving 43 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #8216.

Simplex Trading first reported a position in PPH in Q3 2015 and has held it in 14 quarters since. The position peaked at $618K in Q2 2022. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Simplex Trading held 43 shares of VanEck Pharmaceutical ETF worth $4.7K as of Q2 2026.
  • Simplex Trading sold 4,930 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $510K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8216 holding.
  • Simplex Trading first reported a position in VanEck Pharmaceutical ETF in Q3 2015 and has held it in 14 quarters since.
  • Simplex Trading's VanEck Pharmaceutical ETF position peaked at $618K in Q2 2022.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.